Results 101 to 110 of about 784,112 (127)

Duchenne muscular dystrophy: recent insights in brain related comorbidities. [PDF]

Nat Commun
Vaillend C, Aoki Y, Mercuri E, Hendriksen J, Tetorou K, Goyenvalle A, Muntoni F.   +6 more
europepmc   +1 more source

Identification of suitable qPCR reference genes for the normalization of gene expression in the BL10-mdx and D2-mdx mouse models of Duchenne muscular dystrophy. [PDF]

PLoS One
Putker K, Schneider AF, Van De Vijver D, Hildyard J, Aartsma-Rus A, van Putten M.   +5 more
europepmc   +1 more source

Abstracts from "Imaging in Neuromuscular Disease 2019: Second International Conference on Imaging in Neuromuscular Disease, 17th - 19th November 2019 | Berlin, Germany". [PDF]

J Neuromuscul Dis, 2019
europepmc   +1 more source

Phase I and pharmacological study of sequential intravenous topotecan and oral etoposide. [PDF]

Br J Cancer, 1997
Herben VM, ten Bokkel Huinink WW, Dubbelman AC, Mandjes IA, Groot Y, van Gortel-van Zomeren DM, Beijnen JH.   +6 more
europepmc   +1 more source

The bioequivalence study design recommendations for immediate-release solid oral dosage forms in the international pharmaceutical regulators programme participating regulators and organisations: differences and commonalities. [PDF]

J Pharm Pharm Sci
Fernandes EAF, van Oudtshoorn J, Tam A, González LCA, Aurela EG, Potthast H, Mettke K, Kuribayashi R, Shimojo K, Kasuga M, Morales L, Rodríguez Z, Jones B, Ahn C, Yun E, Kim SH, Rodrigues C, Tiong T, Crane C, Walther C, Roost MS, Chen TL, Hsu LF, Braddy AC, García-Arieta A, Abalos I, Divinsky M, Alsuwyeh A, Alzenaidy B, Alharf A.   +29 more
europepmc   +1 more source

Abstracts of the 18^th UK Neuromuscular Translational Research Conference 15^th and 16^th April 2025. [PDF]

J Neuromuscul Dis
europepmc   +1 more source